Literature DB >> 28778918

Comorbidities, mortality and causes of death among patients with tuberculosis in Denmark 1998-2010: a nationwide, register-based case-control study.

Andreas Fløe1, Ole Hilberg2, Christian Wejse3,4, Rikke Ibsen5, Anders Løkke1.   

Abstract

OBJECTIVE: To evaluate the impact of comorbidities, age and clinical presentation of TB on mortality among Danish patients with TB.
METHODS: Danish patients with an ICD-10 (International Statistical Classification of Diseases and Related Health Problems 10th Revision) diagnosis of TB in 1998-2010 were identified in the National Patient Registry and matched with controls (1:4) on age, gender, civil status and geography. Comorbid diagnoses up to 3 years before and after TB diagnosis or enrolment as control as well as survival data were obtained from national databases
RESULTS: We included 8433 cases and 33 707 controls. Respiratory diseases were the most common comorbidities among cases (12.4% of cases, 3.8% of controls (p<0.001)). Overall HR of death was 2.45 (2.31; 2.59). Relative mortality was especially increased among younger adults (HR 8.70 (95% CI 5.53 to 13.69) among the 30 to 39-year-olds). While overall mortality increased with Deyo-Charlson comorbidity (DCC) score, relative mortality among cases was highest in the low-DCC group. Additionally, male gender, low income and central nervous system TB were risk factors for death among TB cases. The most common cause of death in both groups was non-lung cancers, among TB cases followed by COPD, TB and lung cancer, all being significantly more common among TB cases.
CONCLUSION: In Denmark, TB carries substantial mortality. Among those who die, 12% are reported to die from TB. A high relative mortality among younger adults underscores the importance of continually targeting high-risk TB groups in low-incidence countries. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  case-control study; cause of death; comorbidity; mortality; tuberculosis

Mesh:

Year:  2017        PMID: 28778918     DOI: 10.1136/thoraxjnl-2016-209240

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  11 in total

Review 1.  Tuberculosis and comorbidities: treatment challenges in patients with comorbid diabetes mellitus and depression.

Authors:  Guillermo Cáceres; Rodrigo Calderon; Cesar Ugarte-Gil
Journal:  Ther Adv Infect Dis       Date:  2022-05-20

2.  The prevalence and risks of major comorbidities among inpatients with pulmonary tuberculosis in China from a gender and age perspective: a large-scale multicenter observational study.

Authors:  Wanli Kang; Jian Du; Song Yang; Jiajia Yu; Hongyan Chen; Jianxiong Liu; Jinshan Ma; Mingwu Li; Jingmin Qin; Wei Shu; Peilan Zong; Yi Zhang; Yongkang Dong; Zhiyi Yang; Zaoxian Mei; Qunyi Deng; Pu Wang; Wenge Han; Meiying Wu; Ling Chen; Xinguo Zhao; Lei Tan; Fujian Li; Chao Zheng; Hongwei Liu; Xinjie Li; A Ertai; Yingrong Du; Fenglin Liu; Wenyu Cui; Quanhong Wang; Xiaohong Chen; Junfeng Han; Qingyao Xie; Yanmei Feng; Wenyu Liu; Peijun Tang; Jianyong Zhang; Jian Zheng; Dawei Chen; Xiangyang Yao; Tong Ren; Yang Li; Yuanyuan Li; Lei Wu; Qiang Song; Mei Yang; Jian Zhang; Yuanyuan Liu; Shuliang Guo; Kun Yan; Xinghua Shen; Dan Lei; Yangli Zhang; Xiaofeng Yan; Liang Li; Shenjie Tang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-22       Impact factor: 3.267

3.  Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005-2015.

Authors:  Ivan S Pradipta; Natasha Van't Boveneind-Vrubleuskaya; Onno W Akkerman; Jan-Willem C Alffenaar; Eelko Hak
Journal:  Antimicrob Resist Infect Control       Date:  2019-07-12       Impact factor: 4.887

4.  Epidemiology of tuberculous lymphadenitis in Denmark: A nationwide register-based study.

Authors:  Victor Dahl Mathiasen; Andreas Halgreen Eiset; Peter Henrik Andersen; Christian Wejse; Troels Lillebaek
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

5.  Social, demographic, health care and co-morbidity predictors of tuberculosis mortality in Amazonas, Brazil: a multiple cause of death approach.

Authors:  Vanderson de Souza Sampaio; Maria Gabriela de Almeida Rodrigues; Leila Cristina Ferreira da Silva; Daniel Barros de Castro; Patrícia Carvalho da Silva Balieiro; Ana Alzira Cabrinha; Antonio José Leal Costa
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

6.  Adherence and Associated Factors of Treatment Regimen in Drug-Susceptible Tuberculosis Patients.

Authors:  Sungho Bea; Hyesung Lee; Ju Hwan Kim; Seung Hun Jang; Hyunjin Son; Jin-Won Kwon; Ju-Young Shin
Journal:  Front Pharmacol       Date:  2021-03-15       Impact factor: 5.810

7.  Risk factors affecting treatment outcomes for pulmonary tuberculosis in Finland 2007-2014: a national cohort study.

Authors:  Virve Korhonen; Outi Lyytikäinen; Jukka Ollgren; Hanna Soini; Tuula Vasankari; Petri Ruutu
Journal:  BMC Public Health       Date:  2020-08-17       Impact factor: 3.295

8.  Tuberculosis deaths are predictable and preventable: Comprehensive assessment and clinical care is the key.

Authors:  Anurag Bhargava; Madhavi Bhargava
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-02-26

9.  Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010-15: a population-based, longitudinal study.

Authors:  Otavio T Ranzani; Laura C Rodrigues; Sidney Bombarda; Cátia M Minto; Eliseu A Waldman; Carlos R R Carvalho
Journal:  Lancet Infect Dis       Date:  2019-10-31       Impact factor: 71.421

10.  Factors influencing harmonized health data collection, sharing and linkage in Denmark and Switzerland: A systematic review.

Authors:  Lester Darryl Geneviève; Andrea Martani; Maria Christina Mallet; Tenzin Wangmo; Bernice Simone Elger
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.